目的 探讨肥胖对哮喘预测指数（API）阳性喘息婴幼儿治疗效果的影响。方法 选取API 阳性的喘息婴幼儿208 例，按Kaup 指数分为肥胖组（93 例）和非肥胖组（115 例）。在急性喘息发作期给予综合治疗，缓解期给予吸入性糖皮质激素（ICS）布地奈德混悬液压缩泵雾化吸入治疗。根据临床控制情况调整ICS治疗用量，共治疗6 个月。治疗后2 周随访1 次，之后每月随访1 次。结果 治疗后2 周、1 个月肥胖组的临床症状缓解率分别为35.5% 及75.3%，低于非肥胖组的53.0% 和87.8%（P < 0.05）。肥胖组患儿在治疗后3 个月、6 个月的喘息发生率及6 个月内因喘息引起的急诊就诊率和住院率均高于非肥胖组（P < 0.05）。结论 肥胖可抑制API 阳性喘息婴幼儿对ICS 治疗的反应。
Abstract
Objective To study the effect of obesity on the treatment outcome of asthma predictive index (API) -positive infants and young children with wheezing. Methods A total of 208 API-positive infants and young children with wheezing were enrolled. According to the Kaup index, the patients were divided into an obese group (n=93) and a non-obese group (n=115). The patients were given multimodality therapy in an acute episode of wheezing and aerosol inhalation of inhaled corticosteroid (ICS) budesonide suspension in the remission stage. The dose of ICS was adjusted according to clinical control. The patients were treated for 6 months, and were followed up at 2 weeks after treatment and once per month afterwards. Results At 2 weeks and 1 month after treatment, the obese group had significantly lower remission rates of clinical symptoms than the non-obese group (35.5%/75.3% vs 53.0%/87.8%; P < 0.05). Compared with the non-obese group, the obese group had significantly higher incidence rates of wheezing at 3 and 6 months after treatment and a significantly higher proportion of patients who visited the emergency service or were hospitalized due to wheezing within 6 months (P < 0.05). Conclusions Obesity can inhibit the response to ICS treatment in API-positive infants and young children with wheezing.
关键词
肥胖 /
哮喘预测指数 /
喘息 /
治疗效果 /
婴幼儿
Key words
Obesity /
Asthma predictive index /
Wheezing /
Treatment outcome /
Infant and young child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Visness CM, London SJ, Daniels JL. Association of childhood obesity with atopic and nonatopic asthma: results from the National Health and Nutrition Examination Survey 1999-2006.[J]. J Asthma, 2010, 47(7): 822-829.
[2] 花静, 孟炜, 吴擢春, 等. 苏州城区幼儿园学龄前儿童发育 性运动协调障碍的环境影响因素研究[J]. 中华儿科杂志,2014, 52(8): 590-595.
[3] 中华医学会儿科学分会呼吸学组, 中华儿科杂志编辑委员 会. 儿童支气管哮喘诊断与防治指南[J]. 中华儿科杂志, 2008, 46(10): 745-753.
[4] 丁宗一, 杜丽蓉. 167065 名中国0-7 岁儿童BMI/Kaup 指数 研究[J]. 中华儿科杂志, 2002, 40(4): 222-224.
[5] Bouzas ML, Solé D, Cardoso MR, et al. Wheezing in infants: frequency, clinical characteristics and treatment[J]. J Pediatr (Rio J), 2012, 88(4): 361-365.
[6] 赵德育. 婴幼儿喘息流行病学及发展趋势[J]. 中国实用儿科 杂志, 2014, 29(6): 401-404.
[7] 孙晶, 黄美梦, 刘洋, 等. 肥胖和母乳喂养对儿童哮喘及哮 喘样症状影响的交互效应[J]. 国际儿科学杂志, 2014, 41(5): 561-564.
[8] Vo P, Bair-Merritt M, Camargo CA. The potential role of vitamin D in the link between obesity and asthma severity/control in children[J]. Expert Rev Respir Med, 2015, 9(3): 309-325.
[9] 向莉, 许巍, 姚瑶, 等. 儿童哮喘国际共识[J]. 中华实用儿科 临床杂志, 2014, 29(1): 67-79.
[10] Pedersen SE, Hurd SS, Lemanske RF Jr, et al; Global Initiative for Asthma. Global strategy for the diagnosis and management of asthma in children 5 years and younger[J]. Pediatr Pulmonol, 2011, 46(1): 1-17.
[11] 殷勇, 尚云晓. 家庭雾化吸入糖皮质激素治疗在儿科呼吸系 统疾病中的应用[J]. 临床儿科杂志, 2014, 32(9): 898-900.
[12] 申昆玲, 邓力, 李云珠, 等. 糖皮质激素雾化吸入疗法在儿 科应用的专家共识(2014 年修订版)[J]. 临床儿科杂志, 2014, 32(6): 504-511.
[13] Forno E, Lescher R, Strunk R, et al; Childhood Asthma Management Program Research Group. Decreased response to inhaled steroids in overweight and obese asthmatic children[J]. J Allergy Clin Immunol, 2011, 127(3): 741-749.
[14] Rasmussen F, Hancox RJ. Mechanisms of obesity in asthma[J]. Curr Opin Allergy Clin Immunol, 2014, 14(1): 35-43.
[15] 苏毅, 杜雪梅, 郝月琴, 等. 吸入布地奈德对肥胖哮喘小鼠 气道炎症及瘦素水平的影响[J]. 中华实用诊断与治疗杂志, 2015, 29(11): 1091-1094.
[16] 钟慧, 洪建国. 儿童支气管哮喘与肥胖[J]. 中国循证儿科杂 志, 2013, 8(1): 66-71.
[17] 陈伟, 曲廷刚, 韩伟, 等. 不同糖皮质激素治疗对肥胖哮喘 小鼠全身和气道的影响[J]. 临床肺科杂志, 2015, 20(5): 781-785.
[18] 洪建国, 钟慧. 肥胖哮喘儿童的管理[J]. 中华儿科杂志, 2012, 50(10): 750-752.
PDF(1307 KB)
